Point Therapeutics Reports Third Quarter 2005 Financial Results

BOSTON--(BUSINESS WIRE)--Nov. 9, 2005--Point Therapeutics, Inc. (NASDAQ: POTP) today reported financial results for the fiscal quarter and nine months ended September 30, 2005. In the third quarter of 2005, Point reported a net loss of $6,716,000 or $0.29 per share, compared with a net loss of $4,294,000, or $0.24 per share, in the third quarter of 2004. For the first nine months of 2005, Point reported a net loss of $16,775,000 or $0.77 per share compared with a net loss of $10,437,000 or $0.61 per share for the first nine months of 2004.

Back to news